Drug Name | (Revlimid®(Lenalidomide |
---|---|
Drug Class |
Immunosuppressant
|
Risk minimization type |
patient guide
|
Specialty (Theraputic area) |
Oncology
|
Risk |
Safety information about risk of Risk of teratogenicity |
patient guide |
|
Dear Healthcare provider letter DHPC |
|
other |
I-secure program |